1. Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models. Issue 8 (8th May 2020) Authors: Dharmavaram, Gouri; Cao, Shufen; Sundaram, Suchitra; Ayyappan, Sabarish; Boughan, Kirsten; Gallogly, Molly; Malek, Ehsan; Metheny, Leland; Tomlinson, Benjamin; Otegbeye, Folashade; Lazarus, Hillard M.; Cooper, Brenda; Fu, Pingfu; de Lima, Marcos; Caimi, Paolo F. Journal: American journal of hematology Issue: Volume 95:Issue 8(2020:Aug.) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aging and transplanting graciously. Issue 10 (October 2015) Authors: de Lima, Marcos Journal: Lancet Issue: Volume 2:Issue 10(2015) Page Start: e398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case–control study. Issue 3 (24th January 2013) Authors: Jabbour, Elias; Mathisen, Michael S.; Garcia‐Manero, Guillermo; Champlin, Richard; Popat, Uday; Khouri, Issa; Giralt, Sergio; Kadia, Tapan; Chen, Julianne; Pierce, Sherry; Koca, Ebru; Daver, Naval; Tanaka, Maria; Rondon, Gabriela; Oran, Betul; Parmar, Simrit; Kantarjian, Hagop; de Lima, Marcos Journal: American journal of hematology Issue: Volume 88:Issue 3(2013:Mar.) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Issue 8 (3rd August 2018) Authors: Malek, Ehsan; Gupta, Vinita; Creger, Richard; Caimi, Paolo; Vatsayan, Anant; Covut, Fahrettin; Bashir, Qaiser; Champlin, Richard; Delgado, Ruby; Rondon, Gabriela; Cooper, Brenda; de Lima, Marcos; Lazarus, Hillard M.; Qazilbash, Muzaffar Journal: Leukemia & lymphoma Issue: Volume 59:Issue 8(2018) Page Start: 1905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AML and the art of remission maintenance. (September 2021) Authors: de Lima, Marcos; Roboz, Gail J.; Platzbecker, Uwe; Craddock, Charles; Ossenkoppele, Gert Journal: Blood reviews Issue: Volume 49(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BAFF receptor antibody for mantle cell lymphoma therapy. (1st January 2021) Authors: Zhang, Keman; Roy, Nand K; Vicioso, Yorleny; Woo, Janghee; Beck, Rose; de Lima, Marcos; Caimi, Paolo; Feinberg, Daniel; Parameswaran, Reshmi Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries. (13th May 2021) Authors: Guha, Avirup; Jain, Prantesh; Fradley, Michael G.; Lenihan, Daniel; Gutierrez, Jahir M.; Jain, Chhavi; de Lima, Marcos; Barnholtz‐Sloan, Jill S.; Oliveira, Guilherme H.; Dowlati, Afshin; Al‐Kindi, Sadeer Journal: Cancer medicine Issue: Volume 10:Number 12(2021) Page Start: 3862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia. Issue 17 (27th April 2017) Authors: Segal, Eric; Martens, Michael; Wang, Hai‐Lin; Brazauskas, Ruta; Weisdorf, Daniel; Sandmaier, Brenda M.; Khoury, H. Jean; de Lima, Marcos; Saber, Wael Journal: Cancer Issue: Volume 123:Issue 17(2017) Page Start: 3346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Issue 12 (14th October 2020) Authors: Ali, Naveed; Tomlinson, Benjamin; Metheny, Leland; Goldstein, Steven C.; Fu, Pingfu; Cao, Shufen; Caimi, Paolo; Patel, Rushang D.; Varela, Juan Carlos; Andrade, Luisa; Balls, Jason W.; Baer, Linda; Smith, Megan; Smith, Tori; Nelson, Megan; de Lima, Marcos; Mori, Shahram Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis. Issue 11 (24th January 2017) Authors: Michelis, Fotios V.; Gupta, Vikas; Zhang, Mei‐Jie; Wang, Hai‐Lin; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Chen, Yi‐Bin; DeFilipp, Zachariah; Gale, Robert Peter; Kebriaei, Partow; Kharfan‐Dabaja, Mohamed; Lazarus, Hillard M.; Nishihori, Taiga; Olsson, Richard F.; Oran, Betul; Rashidi, ... Journal: Cancer Issue: Volume 123:Issue 11(2017) Page Start: 2035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗